Richard Berri, MD
Dr. Richard Berri is a surgical oncologist, Chief of Surgical Oncology, and Medical Director of the Ascension Michigan Oncology service program. He is the creator and Director of the system’s Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program, which is nationally recognized and draws patients from all over the country for its state-of-the-art treatment for patients diagnosed with malignant peritoneal mesothelioma.[1]
Dr. Berri has personally performed over 400 CRS-HIPEC procedures at Ascension St. John Hospital. He has a particular interest in the surgical management of cancers that either originate in or have spread to the peritoneal cavity, as well as abdominal malignancies, liver, pancreas, stomach, colorectal, bile duct, small bowel, and appendiceal cancers. He began the JFW GI Cancer Program and created the first comprehensive HIPEC program in Michigan.[1]
Education and Career
Dr. Berri earned his bachelor’s degree and his Master’s degree from the University of Michigan and then earned his medical degree from Wayne State University. He completed an internship and residency in General Surgery at St. John Hospital and then completed a fellowship in Surgical Oncology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas.[1]
After completing his medical education and training, Dr. Berri returned to Michigan to build Ascension’s hyperthermic intraperitoneal chemotherapy program.
Research
Dr. Berri has spent significant time and effort exploring outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal malignancies. He has authored and co-authored over 30 research works, including the following:
Outcomes following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies: 10 Year experience. Graham, I., Boston, A., Hayward, R., Berri, R.>; American Journal of Surgery. 2024 Feb 6
Extended duration chemoprophylaxis for venous thromboembolism following abdominopelvic oncologic surgery John J. Kanitra, John Holtrop, Ali Jawad, Richard Berri>; Journal of Thrombosis and Thrombolysis. 2020 Jul 1
Benign multicystic peritoneal mesothelioma: literature review and update Momal Chand, Jacob Edens, Tayson Taixin Lin, Ian Jacob Anderson, Richard Berri>; Autopsy & Case Reports. 2020 Jun 5
